Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 210 articles:
HTML format
Text format



Single Articles


    May 2018
  1. COHEN-MEKELBURG S, Tafesh Z, Coburn E, Weg R, et al
    Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 May 14. pii: 10.1007/s10620-018-5109.
    PubMed     Text format     Abstract available


  2. WEIZMAN AV, Sharma R, Afzal NM, Xu W, et al
    Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5096.
    PubMed     Text format     Abstract available


  3. UZZAN M
    Concise Commentary: Calling in Your Marker-Rectal CD30-Positive Cells Differentiate Ulcerative Colitis from Crohn's Disease.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5099.
    PubMed     Text format    


  4. CHETCUTI ZAMMIT S, McAlindon ME, Hale MF, Sidhu R, et al
    Isolated Terminal Ileitis: When Is It Not Crohn's Disease?
    Dig Dis Sci. 2018;63:1367.
    PubMed     Text format    


  5. MOGILEVSKI T, Sparrow MP
    Infliximab Versus Adalimumab in Patients with Biologic-Naive Crohn's Disease: Is the Difference Real?
    Dig Dis Sci. 2018;63:1094-1096.
    PubMed     Text format    


    April 2018
  6. ANDERSON A, Ferris LK, Click B, Ramos-Rivers C, et al
    Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Apr 30. pii: 10.1007/s10620-018-5056.
    PubMed     Text format     Abstract available


  7. PERERA LP, Bhandari S, Liu R, Guilday C, et al
    Advanced Age Does Not Negatively Impact Health-Related Quality of Life in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Apr 30. pii: 10.1007/s10620-018-5076.
    PubMed     Text format     Abstract available


  8. BAR-GIL SHITRIT A, Cohen Y, Hassin O, Ben Ya'acov A, et al
    Correction to: Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.
    Dig Dis Sci. 2018 Apr 27. pii: 10.1007/s10620-018-5084.
    PubMed     Text format     Abstract available


  9. SHAH R, Ho EY, Kramer JR, Richardson P, et al
    Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists.
    Dig Dis Sci. 2018 Apr 16. pii: 10.1007/s10620-018-5042.
    PubMed     Text format     Abstract available


  10. LIMSRIVILAI J, Rao K, Stidham RW, Govani SM, et al
    Systemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile Infection.
    Dig Dis Sci. 2018 Apr 12. pii: 10.1007/s10620-018-5044.
    PubMed     Text format     Abstract available


  11. SHITRIT AB, Cohen Y, Hassin O, Ya'acov AB, et al
    Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.
    Dig Dis Sci. 2018 Apr 6. pii: 10.1007/s10620-018-5048.
    PubMed     Text format     Abstract available


  12. CAVOUNIDIS A, Uhlig HH
    Crohn's Disease in Niemann-Pick Disease Type C1: Caught in the Cross-Fire of Host-Microbial Interactions.
    Dig Dis Sci. 2018;63:811-813.
    PubMed     Text format    


    March 2018
  13. AVALOS DJ, Mendoza-Ladd A, Zuckerman MJ, Bashashati M, et al
    Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5022.
    PubMed     Text format     Abstract available


  14. CALDERA F, Saha S, Wald A, Garmoe CA, et al
    Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5043.
    PubMed     Text format     Abstract available


  15. KERLIN AM, Long M, Kappelman M, Martin C, et al
    Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5040.
    PubMed     Text format     Abstract available


  16. HOLMSTROM RB, Mogensen DV, Brynskov J, Ainsworth MA, et al
    Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5020.
    PubMed     Text format     Abstract available


  17. BERRY N, Sinha SK, Bhattacharya A, Prasad KK, et al
    Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5026.
    PubMed     Text format     Abstract available


  18. NISHIUMI S, Izumi Y, Yoshida M
    Alterations in Docosahexaenoic Acid-Related Lipid Cascades in Inflammatory Bowel Disease Model Mice.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5025.
    PubMed     Text format     Abstract available


  19. FABIAN O, Hradsky O, Drskova T, Mikus F, et al
    Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis.
    Dig Dis Sci. 2018 Mar 14. pii: 10.1007/s10620-018-5018.
    PubMed     Text format     Abstract available


  20. KUSAKA J, Shiga H, Kuroha M, Kimura T, et al
    Residual Lesions on Capsule Endoscopy Is Associated with Postoperative Clinical Recurrence in Patients with Crohn's Disease.
    Dig Dis Sci. 2018;63:768-774.
    PubMed     Text format     Abstract available


  21. LUTHER J, Gala M, Patel SJ, Dave M, et al
    Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways.
    Dig Dis Sci. 2018;63:738-745.
    PubMed     Text format     Abstract available


    February 2018
  22. FLEISHER M, Marsal J, Lee SD, Frado LE, et al
    Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4971.
    PubMed     Text format     Abstract available


  23. MAK WY, Buisson A, Andersen MJ Jr, Lei D, et al
    Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2018 Feb 22. pii: 10.1007/s10620-018-4980.
    PubMed     Text format     Abstract available


  24. KIELY CJ, Clark A, Bhattacharyya J, Moran GW, et al
    Acetarsol Suppositories: Effective Treatment for Refractory Proctitis in a Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Feb 19. pii: 10.1007/s10620-017-4890.
    PubMed     Text format     Abstract available


  25. MATSUOKA K, Uemura Y, Kanai T, Kunisaki R, et al
    Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis.
    Dig Dis Sci. 2018 Feb 15. pii: 10.1007/s10620-018-4946.
    PubMed     Text format     Abstract available


  26. MICIC D, Yarur A, Gonsalves A, Rao VL, et al
    Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
    Dig Dis Sci. 2018 Feb 8. pii: 10.1007/s10620-018-4941.
    PubMed     Text format     Abstract available


    January 2018
  27. FERNANDEZ-BLANCO JI, Fernandez-Diaz G, Cara C, Vera MI, et al
    Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
    Dig Dis Sci. 2018 Jan 25. pii: 10.1007/s10620-018-4935.
    PubMed     Text format     Abstract available


  28. BODEN EK, Shows DM, Chiorean MV, Lord JD, et al
    Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 25. pii: 10.1007/s10620-018-4924.
    PubMed     Text format     Abstract available


  29. LUKACH AJ, Saul MI, Ferris LK, Swoger JM, et al
    Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 22. pii: 10.1007/s10620-018-4919.
    PubMed     Text format     Abstract available


  30. FEUERSTEIN JD, Curran T, Alosilla M, Cataldo T, et al
    Mortality Is Rare Following Elective and Non-elective Surgery for Ulcerative Colitis, but Mild Postoperative Complications Are Common.
    Dig Dis Sci. 2018 Jan 20. pii: 10.1007/s10620-018-4922.
    PubMed     Text format     Abstract available


  31. ANDRADE P, Lopes S, Gaspar R, Nunes A, et al
    Anti-Tumor Necrosis Factor-alpha-Induced Dermatological Complications in a Large Cohort of Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Jan 18. pii: 10.1007/s10620-018-4921.
    PubMed     Text format     Abstract available


  32. PAPAMICHAEL K, Vajravelu RK, Osterman MT, Cheifetz AS, et al
    Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 16. pii: 10.1007/s10620-018-4917.
    PubMed     Text format     Abstract available


    December 2017
  33. SHAMAH S, Schneider J, Korelitz BI
    High Incidence of Recurrent Crohn's Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up.
    Dig Dis Sci. 2017 Dec 28. pii: 10.1007/s10620-017-4873.
    PubMed     Text format     Abstract available


  34. GIUFFRIDA P, Corazza GR, Di Sabatino A
    Old and New Lymphocyte Players in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Dec 23. pii: 10.1007/s10620-017-4892.
    PubMed     Text format     Abstract available


    November 2017
  35. FEUERSTEIN JD, Papamichael K, Popejoy S, Nadelson A, et al
    Targeted Physician Education and Standardizing Documentation Improves Documented Reporting with Inflammatory Bowel Disease Quality Measures in a Large Academic and Private Practice.
    Dig Dis Sci. 2017 Nov 17. doi: 10.1007/s10620-017-4845.
    PubMed     Text format     Abstract available


  36. GURVITS GE
    Lax Prophylaxis: Vaccinating the Inflammatory Bowel Disease Patient.
    Dig Dis Sci. 2017 Nov 10. doi: 10.1007/s10620-017-4836.
    PubMed     Text format    


  37. FISCHER M, Campbell SC, Calley CSJ, Helper DJ, et al
    Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up.
    Dig Dis Sci. 2017;62:3131-3137.
    PubMed     Text format     Abstract available


  38. HAR-NOY O, Katz L, Avni T, Battat R, et al
    Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2017;62:2982-2990.
    PubMed     Text format     Abstract available


    October 2017
  39. MORSHEDZADEH N, Rahimlou M, Asadzadeh Aghdaei H, Shahrokh S, et al
    Association Between Adipokines Levels with Inflammatory Bowel Disease (IBD): Systematic Reviews.
    Dig Dis Sci. 2017 Oct 30. doi: 10.1007/s10620-017-4806.
    PubMed     Text format     Abstract available


  40. TSE CS, Deepak P, Smyrk TC, Raffals LE, et al
    Isolated Acute Terminal Ileitis Without Preexisting Inflammatory Bowel Disease Rarely Progresses to Crohn's Disease.
    Dig Dis Sci. 2017 Oct 24. doi: 10.1007/s10620-017-4803.
    PubMed     Text format     Abstract available


  41. FINE S, Nee J, Thakuria P, Duff B, et al
    Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 24. doi: 10.1007/s10620-017-4781.
    PubMed     Text format     Abstract available


  42. CAMPBELL JP, Burton E, Wymer S, Shaw M, et al
    Out-of-Pocket Cost Is a Barrier to Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 20. doi: 10.1007/s10620-017-4808.
    PubMed     Text format     Abstract available


  43. CALLOWAY A, Dalal R, Beaulieu DB, Duley C, et al
    Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 20. doi: 10.1007/s10620-017-4800.
    PubMed     Text format     Abstract available


  44. DAI C, Jiang M, Sun MJ
    Fecal Calprotectin in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 17. doi: 10.1007/s10620-017-4799.
    PubMed     Text format    


  45. LINARES PM, Algaba A, Urzainqui A, Guijarro-Rojas M, et al
    Ratio of Circulating Estrogen Receptors Beta and Alpha (ERbeta/ERalpha) Indicates Endoscopic Activity in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:2744-2754.
    PubMed     Text format     Abstract available


  46. SEO H, Ye BD, Song EM, Lee SH, et al
    Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn's Disease: A Hospital-Based Cohort Study from Korea.
    Dig Dis Sci. 2017;62:2882-2893.
    PubMed     Text format     Abstract available


  47. LI J, Yan Y, Meng Z, Liu S, et al
    Microscopic Colitis Evolved Into Inflammatory Bowel Diseases Is Characterized by Increased Th1/Tc1 Cells in Colonic Mucosal Lamina Propria.
    Dig Dis Sci. 2017;62:2755-2767.
    PubMed     Text format     Abstract available


    September 2017
  48. PUOLANNE AM, Kolho KL, Alfthan H, Ristimaki A, et al
    Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4770.
    PubMed     Text format     Abstract available


  49. HUSSEY M, Holleran G, Smith S, Sherlock M, et al
    The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 20. doi: 10.1007/s10620-017-4753.
    PubMed     Text format     Abstract available


  50. HAAS L, Chevalier R, Major BT, Enders F, et al
    Biologic Agents Are Associated with Excessive Weight Gain in Children with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 11. doi: 10.1007/s10620-017-4745.
    PubMed     Text format     Abstract available


  51. KUMAR V, Shah Y, Patel D, Khan N, et al
    Elderly-Onset and Adult-Onset Ulcerative Colitis Are More Similar than Previously Reported in a Nationwide Cohort.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4734.
    PubMed     Text format     Abstract available


  52. DE BARROS KSC, Flores C, Harlacher L, Francesconi CFM, et al
    Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery.
    Dig Dis Sci. 2017;62:2481-2488.
    PubMed     Text format     Abstract available


  53. BELLOLIO ROTH F, Gomez J, Cerda J
    Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012.
    Dig Dis Sci. 2017;62:2311-2317.
    PubMed     Text format     Abstract available


  54. SHAH A, Talley NJ, Walker M, Koloski N, et al
    Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?
    Dig Dis Sci. 2017;62:2472-2480.
    PubMed     Text format     Abstract available


    August 2017
  55. CASTANEDA G, Liu B, Torres S, Bhuket T, et al
    Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.
    Dig Dis Sci. 2017 Aug 30. doi: 10.1007/s10620-017-4733.
    PubMed     Text format     Abstract available


  56. POURAFKARI L, Masnadi-Shirazi K, Taban M, Mohammadi S, et al
    Higher Frequency of Nocturnal Blood Pressure Dipping but Not Heart Rate Dipping in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Aug 23. doi: 10.1007/s10620-017-4712.
    PubMed     Text format     Abstract available


  57. PHAM HV, Hasan I, Udaltsova N, Pham K, et al
    Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.
    Dig Dis Sci. 2017 Aug 23. doi: 10.1007/s10620-017-4716.
    PubMed     Text format     Abstract available


  58. ZIZZO MG, Serio R
    Therapeutic Potential of the Gabaergic System in Ulcerative Colitis: Current Status and Perspectives.
    Dig Dis Sci. 2017 Aug 5. doi: 10.1007/s10620-017-4709.
    PubMed     Text format    


  59. CARRASCO A, Fernandez-Banares F
    Th1 Pathway: The Missing Link Between Inflammatory Bowel Disease and Microscopic Colitis?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4692.
    PubMed     Text format    


  60. ALLOCCA M, Fiorino G, Danese S
    Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4693.
    PubMed     Text format    


  61. KAMAT N, Ganesh Pai C, Surulivel Rajan M, Kamath A, et al
    Cost of Illness in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Aug 1. doi: 10.1007/s10620-017-4690.
    PubMed     Text format     Abstract available


  62. BAFFORD AC, Latushko A, Hansraj N, Jambaulikar G, et al
    The Use of Temporary Fecal Diversion in Colonic and Perianal Crohn's Disease Does Not Improve Outcomes.
    Dig Dis Sci. 2017;62:2079-2086.
    PubMed     Text format     Abstract available


  63. JEWEL SAMADDER N, Valentine JF, Guthery S, Singh H, et al
    Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
    Dig Dis Sci. 2017;62:2126-2132.
    PubMed     Text format     Abstract available


    July 2017
  64. MOURAD FH, Yau Y, Wasinger VC, Leong RW, et al
    Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.
    Dig Dis Sci. 2017 Jul 17. doi: 10.1007/s10620-017-4673.
    PubMed     Text format     Abstract available


  65. SARTINI A, Gitto S, Villa E
    Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?
    Dig Dis Sci. 2017 Jul 4. doi: 10.1007/s10620-017-4665.
    PubMed     Text format    


    June 2017
  66. AGGARWAL S, Ahuja V, Paul J
    Attenuated GABAergic Signaling in Intestinal Epithelium Contributes to Pathogenesis of Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 30. doi: 10.1007/s10620-017-4662.
    PubMed     Text format     Abstract available


  67. SMITS LJT, Grelack A, Derikx LAAP, de Jong DJ, et al
    Long-Term Clinical Outcomes After Switching from Remicade(R) to Biosimilar CT-P13 in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 30. doi: 10.1007/s10620-017-4661.
    PubMed     Text format     Abstract available


  68. ARGUELLES-ARIAS F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, et al
    Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
    Dig Dis Sci. 2017 Jun 28. doi: 10.1007/s10620-017-4657.
    PubMed     Text format    


  69. KIM ES, Kim KO, Jang BI, Kim EY, et al
    Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 21. doi: 10.1007/s10620-017-4634.
    PubMed     Text format     Abstract available


  70. ELURI S, Parian AM, Limketkai BN, Ha CY, et al
    Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 19. doi: 10.1007/s10620-017-4652.
    PubMed     Text format     Abstract available


  71. LIU L, Li X
    NLRP3 Inflammasome in Inflammatory Bowel Disease: Friend or Foe?
    Dig Dis Sci. 2017 Jun 19. doi: 10.1007/s10620-017-4650.
    PubMed     Text format    


  72. JUNG YS, Han M, Kim WH, Park S, et al
    Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
    Dig Dis Sci. 2017 Jun 7. doi: 10.1007/s10620-017-4640.
    PubMed     Text format     Abstract available


  73. FRIEDMAN S
    Gestational Weight Gain: A New Factor Influencing Pregnancy Outcomes in Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 2. doi: 10.1007/s10620-017-4635.
    PubMed     Text format    


  74. LI J, Ueno A, Iacucci M, Fort Gasia M, et al
    Crossover Subsets of CD4+ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 1. doi: 10.1007/s10620-017-4596.
    PubMed     Text format     Abstract available


  75. CAMPOS C, Perrey A, Lambert C, Pereira B, et al
    Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Dig Dis Sci. 2017;62:1628-1636.
    PubMed     Text format     Abstract available


  76. OBI K, Hinton A, Sobotka L, Levine E, et al
    Hospital-Acquired Conditions Are Associated with Worse Outcomes in Crohn's Disease-Related Hospitalizations.
    Dig Dis Sci. 2017;62:1621-1627.
    PubMed     Text format     Abstract available


  77. NAFTALI T, Mechulam R, Marii A, Gabay G, et al
    Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.
    Dig Dis Sci. 2017;62:1615-1620.
    PubMed     Text format     Abstract available


  78. KIM JW, Lee HS, Ye BD, Yang SK, et al
    Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:1607-1614.
    PubMed     Text format     Abstract available


  79. FUMERY M, Kohut M, Gower-Rousseau C, Duhamel A, et al
    Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study.
    Dig Dis Sci. 2017;62:1571-1579.
    PubMed     Text format     Abstract available


    May 2017
  80. MILLER TL, Lee D, Giefer M, Wahbeh G, et al
    Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report.
    Dig Dis Sci. 2017 May 27. doi: 10.1007/s10620-017-4616.
    PubMed     Text format     Abstract available


  81. TASSON L, Canova C, Vettorato MG, Savarino E, et al
    Influence of Diet on the Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 May 26. doi: 10.1007/s10620-017-4620.
    PubMed     Text format     Abstract available


  82. RINAWI F, Assa A, Bashir H, Peleg S, et al
    Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4623.
    PubMed     Text format     Abstract available


  83. ZULLOW S, Jambaulikar G, Rustgi A, Quezada S, et al
    Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4614.
    PubMed     Text format     Abstract available


  84. LAZARIDIS LD, Pistiki A, Giamarellos-Bourboulis EJ, Georgitsi M, et al
    Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4609.
    PubMed     Text format     Abstract available


    April 2017
  85. MEIGHANI A, Hart BR, Bourgi K, Miller N, et al
    Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 27. doi: 10.1007/s10620-017-4580.
    PubMed     Text format     Abstract available


  86. SAEZ-GONZALEZ E, Moret I, Alvarez-Sotomayor D, Diaz-Jaime FC, et al
    Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 21. doi: 10.1007/s10620-017-4577.
    PubMed     Text format     Abstract available


  87. JIANG Y, Lin O, Sinha SR
    Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure.
    Dig Dis Sci. 2017 Apr 17. doi: 10.1007/s10620-017-4574.
    PubMed     Text format     Abstract available


  88. PIECHOTA-POLANCZYK A, Wlodarczyk M, Sobolewska-Wlodarczyk A, Jonakowski M, et al
    Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
    Dig Dis Sci. 2017 Apr 8. doi: 10.1007/s10620-017-4568.
    PubMed     Text format     Abstract available


  89. CAO B, Zhou X, Ma J, Zhou W, et al
    Role of MiRNAs in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 8. doi: 10.1007/s10620-017-4567.
    PubMed     Text format     Abstract available


  90. ULLMAN TA, Itzkowitz SH
    Prognosis of Colorectal Cancer in Inflammatory Bowel Disease: Data from a State Registry.
    Dig Dis Sci. 2017 Apr 3. doi: 10.1007/s10620-017-4557.
    PubMed     Text format    


  91. HIRTEN R, Sands BE, Cohen BL
    The Whys and Hows of Fourth-Year Inflammatory Bowel Disease Fellowships.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4555.
    PubMed     Text format    


  92. SOFIA MA, Rubin DT
    The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.
    Dig Dis Sci. 2017;62:833-842.
    PubMed     Text format     Abstract available


  93. BENET-CAMPOS C, Cuellar C, Garcia-Ballesteros C, Zamora V, et al
    Determination of Anti-Anisakis Simplex Antibodies and Relationship with alphabeta and gammadelta Lymphocyte Subpopulations in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:934-943.
    PubMed     Text format     Abstract available


  94. CAO Y, Ding Z, Han C, Shi H, et al
    Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2017;62:851-860.
    PubMed     Text format     Abstract available


  95. KAUNITZ JD
    Development of Monoclonal Antibodies: The Dawn of mAb Rule.
    Dig Dis Sci. 2017;62:831-832.
    PubMed     Text format    


    March 2017
  96. ALLEGRETTI JR, Barnes EL, Stevens B, Storm M, et al
    Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab.
    Dig Dis Sci. 2017 Mar 29. doi: 10.1007/s10620-017-4549.
    PubMed     Text format     Abstract available


  97. BENGTSON MB, Martin CF, Aamodt G, Vatn MH, et al
    Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort.
    Dig Dis Sci. 2017 Mar 22. doi: 10.1007/s10620-017-4547.
    PubMed     Text format     Abstract available


  98. KHAN N, Patel D, Shah Y, Yang YX, et al
    A Novel Model for Predicting Incident Moderate to Severe Anemia and Iron Deficiency in Patients with Newly Diagnosed Ulcerative Colitis.
    Dig Dis Sci. 2017 Mar 11. doi: 10.1007/s10620-017-4512.
    PubMed     Text format     Abstract available


  99. ARGUELLES-ARIAS F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, et al
    Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
    Dig Dis Sci. 2017 Mar 9. doi: 10.1007/s10620-017-4511.
    PubMed     Text format     Abstract available


  100. CARR RM, Patel A, Bownik H, Oranu A, et al
    Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4495.
    PubMed     Text format     Abstract available


  101. BOLTIN D, Kamenetsky Z, Perets TT, Snir Y, et al
    Circulating Bone Marrow-Derived CD45-/CD34+/CD133+/VEGF+ Endothelial Progenitor Cells in Adults with Crohn's Disease.
    Dig Dis Sci. 2017;62:633-638.
    PubMed     Text format     Abstract available


  102. DIETRICH C, Singh SR
    Circulating Endothelial Progenitor Cells in Crohn's Disease: An EPiC in the Making?
    Dig Dis Sci. 2017;62:567-568.
    PubMed     Text format    


  103. TRIADAFILOPOULOS G, Eisenstat S, Dormady S, Sinha R, et al
    When It Rains It Pours: Evolving, Complicated Small Intestinal Crohn's Disease.
    Dig Dis Sci. 2017;62:577-582.
    PubMed     Text format    


    February 2017
  104. RAI T, Choudhury BN, Kedia S, Bopanna S, et al
    Short-Term Clinical Response to Corticosteroids Can Predict Long-Term Natural History of Ulcerative Colitis: Prospective Study Experience.
    Dig Dis Sci. 2017 Feb 4. doi: 10.1007/s10620-017-4450.
    PubMed     Text format     Abstract available


  105. NARULA N, Cooray M, Anglin R, Muqtadir Z, et al
    Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn's Disease in Remission: A Pilot Randomized Double-Blind Controlled Study.
    Dig Dis Sci. 2017;62:448-455.
    PubMed     Text format     Abstract available


  106. BODELIER AG, Jonkers D, van den Heuvel T, de Boer E, et al
    High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
    Dig Dis Sci. 2017;62:465-472.
    PubMed     Text format     Abstract available


  107. KOTZE PG, Saab MP, Saab B, da Silva Kotze LM, et al
    Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
    Dig Dis Sci. 2017;62:456-464.
    PubMed     Text format     Abstract available


    January 2017
  108. SCAIOLI E, Sartini A, Liverani E, Digby RJ, et al
    Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.
    Dig Dis Sci. 2017 Jan 21. doi: 10.1007/s10620-017-4454.
    PubMed     Text format     Abstract available


  109. LEE HS, Lim YJ, Shim KN, Moon CM, et al
    Diagnostic Value of Small Bowel Capsule Endoscopy in Isolated Ileitis: A CAPENTRY Study.
    Dig Dis Sci. 2017;62:180-187.
    PubMed     Text format     Abstract available


  110. SRIDHAR A, Cwiak CA, Kaunitz AM, Allen RH, et al
    Contraceptive Considerations for Women with Gastrointestinal Disorders.
    Dig Dis Sci. 2017;62:54-63.
    PubMed     Text format     Abstract available


  111. STEVENS BW, Borren NZ, Velonias G, Conway G, et al
    Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2017;62:197-206.
    PubMed     Text format     Abstract available


  112. FORTINSKY KJ, Kevans D, Qiang J, Xu W, et al
    Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.
    Dig Dis Sci. 2017;62:188-196.
    PubMed     Text format     Abstract available


  113. XIE M, Qin H, Luo Q, He X, et al
    Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
    Dig Dis Sci. 2017;62:115-123.
    PubMed     Text format     Abstract available


  114. REGALIA K, Shelton A, Berry G, Triadafilopoulos G, et al
    Pulmonary Crohn's Disease.
    Dig Dis Sci. 2017;62:64-67.
    PubMed     Text format    


    December 2016
  115. TAKAHARA I, Takeshima F, Ichikawa T, Matsuzaki T, et al
    Prevalence of Restless Legs Syndrome in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4420.
    PubMed     Text format     Abstract available


  116. KORELITZ BI
    Enduring Value of Thiopurines for Inflammatory Bowel Disease Therapy.
    Dig Dis Sci. 2016 Dec 26. doi: 10.1007/s10620-016-4419.
    PubMed     Text format    


  117. TAN MC, El-Serag HB, Hou JK
    Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016 Dec 23. doi: 10.1007/s10620-016-4414.
    PubMed     Text format     Abstract available


  118. BERNSTEIN GR, Pickett-Blakely O
    De Novo Inflammatory Bowel Disease After Bariatric Surgery: A Case Series and Literature Review.
    Dig Dis Sci. 2016 Dec 23. doi: 10.1007/s10620-016-4412.
    PubMed     Text format    


  119. TAXONERA C, Iglesias E, Munoz F, Calvo M, et al
    Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  120. FEUERSTEIN JD, Sehgal P, Rao V, Malladi VR, et al
    Inflammatory Bowel Disease-Related Abstracts Presented at National Conferences in the USA Are Frequently Unpublished as Full Manuscripts.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  121. WANNHOFF A, Rupp C, Friedrich K, Knierim J, et al
    Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    November 2016
  122. PRIEUX-KLOTZ C, Nahon S, Amiot A, Sinayoko L, et al
    Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  123. LOPEZ-SANROMAN A, Carpio D, Calvet X, Romero C, et al
    Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    October 2016
  124. PADHAN RK, Kedia S, Garg SK, Bopanna S, et al
    Long-Term Disease Course and Pregnancy Outcomes in Women with Inflammatory Bowel Disease: An Indian Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  125. LATUSHKO A, Ghazi LJ
    A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis.
    Dig Dis Sci. 2016.
    PubMed     Text format    


    September 2016
  126. BARNES EL, Goldin A, Winter RW, Collins E, et al
    Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  127. SUSKIND DL, Wahbeh G, Cohen SA, Damman CJ, et al
    Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  128. ANDERSON AJ, Click B, Ramos-Rivers C, Babichenko D, et al
    Development of an Inflammatory Bowel Disease Research Registry Derived from Observational Electronic Health Record Data for Comprehensive Clinical Phenotyping.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    August 2016
  129. DOTAN I, Levy-Nissenbaum E, Chowers Y, Fich A, et al
    Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  130. CLEVELAND NK, Rodriquez D, Wichman A, Pan I, et al
    Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    July 2016
  131. OPSTELTEN JL, Beelen RM, Leenders M, Hoek G, et al
    Exposure to Ambient Air Pollution and the Risk of Inflammatory Bowel Disease: A European Nested Case-Control Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  132. SUBRAMANIAN V, Chatu S, Echterdiek F, Banerjee A, et al
    Patients with Endoscopically Visible Polypoid Adenomatous Lesions Within the Extent of Ulcerative Colitis Have an Increased Risk of Colorectal Cancer Despite Endoscopic Resection.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    June 2016
  133. STRIZ I
    B Cell-Activating Factor (BAFF) in Inflammatory Bowel Disease: BAFFling No Longer?
    Dig Dis Sci. 2016.
    PubMed     Text format    


    May 2016
  134. CARD TR, Langan SM, Chu TP
    Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  135. TALEBAN S, Stewart KO, Li DK, Singh P, et al
    Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    April 2016
  136. ALSALEH A, Gaidos JK, Kang L, Kuemmerle JF, et al
    Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  137. LIU JJ, Kay TM, Davis EM, Lou Y, et al
    Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  138. BAR-GIL SHITRIT A, Grisaru-Granovsky S, Ben Ya'acov A, Goldin E, et al
    Management of Inflammatory Bowel Disease During Pregnancy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  139. REICH JS, Farraye FA, Wasan SK
    Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  140. ZHANG P, Liu X, Guo A, Xiong J, et al
    B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  141. WENGROWER D, Koslowsky B, Peleg U, Mazuz B, et al
    Hearing Loss in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  142. CANKURTARAN E, Ekiz F, Hamamci M, Akinci H, et al
    Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn's Disease.
    Dig Dis Sci. 2016;61:1206-7.
    PubMed     Text format    


  143. GUNASEKEERA V, Mendall MA, Chan D, Kumar D, et al
    Treatment of Crohn's Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled Trial.
    Dig Dis Sci. 2016;61:1148-57.
    PubMed     Text format     Abstract available


  144. WILLIET N, Paul S, Peyrin-Biroulet L, Roblin X, et al
    Pharmacokinetics of Infliximab and Reduction of Treatment for Inflammatory Bowel Diseases.
    Dig Dis Sci. 2016;61:990-5.
    PubMed     Text format     Abstract available


  145. LEE D, Suskind D
    Individualized Food-Based Dietary Therapy for Crohn's Disease: Are We Making Progress?
    Dig Dis Sci. 2016;61:958-60.
    PubMed     Text format    


    March 2016
  146. MARTINS FS
    Fecal Microbiota Transplantation for Ulcerative Colitis: FoMenTing Change?
    Dig Dis Sci. 2016.
    PubMed     Text format    


  147. PAUL S, Shuja A, Tam I, Kim EM, et al
    Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    February 2016
  148. GARCIA-BOSCH O, Aceituno M, Ordas I, Etchevers J, et al
    Long-Term Follow-Up of Patients Treated with Infliximab for Ulcerative Colitis: Predictive Factors of Response-An Observational Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  149. OZA SS, Pabby V, Dodge LE, Hacker MR, et al
    Factors Associated with the Success of In Vitro Fertilization in Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  150. ADAR T, Shteingart S, Ben-Ya'acov A, Shitrit AB, et al
    The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  151. SAPIR T, Moreo K, Carter JD, Greene L, et al
    Continuing Medical Education Improves Gastroenterologists' Compliance with Inflammatory Bowel Disease Quality Measures.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  152. LEE NS, Pola S, Groessl EJ, Rivera-Nieves J, et al
    Opportunities for Improvement in the Care of Patients Hospitalized for Inflammatory Bowel Disease-Related Colitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  153. TIAN Z, Liu J, Liao M, Li W, et al
    Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  154. SOBOLEWSKA A, Wlodarczyk M, Stec-Michalska K, Fichna J, et al
    Mean Platelet Volume in Crohn's Disease Patients Predicts Sustained Response to a 52-Week Infliximab Therapy: A Pilot Study.
    Dig Dis Sci. 2016;61:542-9.
    PubMed     Text format     Abstract available


  155. TALEBAN S, Van Oijen MG, Vasiliauskas EA, Fleshner PR, et al
    Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's Colitis.
    Dig Dis Sci. 2016;61:550-9.
    PubMed     Text format     Abstract available


    January 2016
  156. O'TOOLE A, Lucci M, Korzenik J
    Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  157. SHAPIRO JM, Hagin SE, Shah SA, Bright R, et al
    Corticosteroid Use in a Prospective, Community-Based Cohort of Newly Diagnosed Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  158. SUGIMOTO K, Ikeya K, Iida T, Kawasaki S, et al
    An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
    Dig Dis Sci. 2016;61:99-106.
    PubMed     Text format     Abstract available


    December 2015
  159. FEATHERS A, Yen T, Yun L, Strizich G, et al
    Internet Searches About Therapies Do Not Impact Willingness to Accept Prescribed Therapy in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  160. SENGUPTA N, Yee E, Feuerstein JD
    Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  161. OKAFOR PN, Farraye FA, Okafor AT, Erim DO, et al
    Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease.
    Dig Dis Sci. 2015;60:3743-55.
    PubMed     Text format     Abstract available


    November 2015
  162. BARNES D, Kerner J
    Severe Lactic Acidosis in a Parenteral Nutrition-Dependent Teenager with Ulcerative Colitis.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  163. LICHTENSTEIN GR, Gordon GL, Zakko S, Murthy U, et al
    Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  164. LICHTENSTEIN GR
    Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  165. ZOLLNER-SCHWETZ I, Herzog KA, Feierl G, Leitner E, et al
    The Toxin-Producing Pathobiont Klebsiella oxytoca Is Not Associated with Flares of Inflammatory Bowel Diseases.
    Dig Dis Sci. 2015;60:3393-8.
    PubMed     Text format     Abstract available


  166. TAKEYAMA H, Mizushima T, Iijima H, Shinichiro S, et al
    Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
    Dig Dis Sci. 2015;60:3418-23.
    PubMed     Text format     Abstract available


    October 2015
  167. OU B, Zhao J, Guan S, Lu A, et al
    Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  168. KOUTROUMPAKIS E, Ramos-Rivers C, Regueiro M, Hashash JG, et al
    Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  169. MALATY HM, Sansgiry S, Artinyan A, Hou JK, et al
    Time Trends, Clinical Characteristics, and Risk Factors of Chronic Anal Fissure Among a National Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  170. THAPA SD, Hadid H, Usman M, Imam W, et al
    Predictors of Thiopurine Treatment Failure in Biologic-Naive Ulcerative Colitis Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  171. ASHIZUKA S, Inatsu H, Kita T, Kitamura K, et al
    Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  172. QAZI T, Shah B, El-Dib M, Farraye FA, et al
    The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  173. GROVER Z, Lewindon P
    Two-Year Outcomes After Exclusive Enteral Nutrition Induction Are Superior to Corticosteroids in Pediatric Crohn's Disease Treated Early with Thiopurines.
    Dig Dis Sci. 2015;60:3069-74.
    PubMed     Text format     Abstract available


  174. TORKI M, Gholamrezaei A, Mirbagher L, Danesh M, et al
    Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2015;60:3085-91.
    PubMed     Text format     Abstract available


    September 2015
  175. GAJENDRAN M, Umapathy C, Loganathan P, Hashash JG, et al
    Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  176. PETAN T, Krizaj I
    Is iPLAbeta a Novel Target for the Development of New Strategies to Alleviate Inflammatory Bowel Disease?
    Dig Dis Sci. 2015.
    PubMed     Text format    


  177. ADAR T, Grisaru-Granovsky S, Ben Ya'acov A, Goldin E, et al
    Pregnancy and the Immune System: General Overview and the Gastroenterological Perspective.
    Dig Dis Sci. 2015;60:2581-9.
    PubMed     Text format     Abstract available


  178. ANDRADE P, Lopes S, Albuquerque A, Osorio F, et al
    Oral Lichen Planus in IBD Patients: A Paradoxical Adverse Effect of Anti-TNF-alpha Therapy.
    Dig Dis Sci. 2015;60:2746-9.
    PubMed     Text format     Abstract available


  179. VANDE CASTEELE N, Gils A
    Preemptive Dose Optimization Using Therapeutic Drug Monitoring for Biologic Therapy of Crohn's Disease: Avoiding Failure While Lowering Costs?
    Dig Dis Sci. 2015;60:2571-3.
    PubMed     Text format    


  180. STEENHOLDT C, Brynskov J, Thomsen OO, Munck LK, et al
    Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.
    Dig Dis Sci. 2015;60:2762-70.
    PubMed     Text format     Abstract available


    August 2015
  181. JAMALI R
    Important Issues Regarding Serum 25-Hydroxy Vitamin D Measurement in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  182. DEFILIPPIS EM, Tabani S, Warren RU, Christos PJ, et al
    Exercise and Self-Reported Limitations in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  183. WILSON A, Teft WA, Morse BL, Choi YH, et al
    Erratum to: Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  184. KUO CJ, Yu KH, See LC, Chiu CT, et al
    The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study.
    Dig Dis Sci. 2015;60:2454-62.
    PubMed     Text format     Abstract available


  185. SHAH ED, Siegel CA, Chong K, Melmed GY, et al
    Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability.
    Dig Dis Sci. 2015;60:2408-18.
    PubMed     Text format     Abstract available


  186. RAFTERY T, Merrick M, Healy M, Mahmud N, et al
    Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn's Disease in Clinical Remission.
    Dig Dis Sci. 2015;60:2427-35.
    PubMed     Text format     Abstract available


    July 2015
  187. WILSON A, Teft WA, Morse BM, Choi YH, et al
    Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  188. TRINDADE IA, Ferreira C, Pinto-Gouveia J
    Ulcerative Colitis Symptomatology and Depression: The Exacerbator Role of Maladaptive Psychological Processes.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  189. SCALDAFERRI F, Vetrano S
    Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms.
    Dig Dis Sci. 2015;60:1873-5.
    PubMed     Text format    


  190. VEERAPPAN SG, Healy M, Walsh BJ, O'Morain CA, et al
    Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn's Disease.
    Dig Dis Sci. 2015;60:2119-29.
    PubMed     Text format     Abstract available


    June 2015
  191. GEORGE LA, Gadani A, Cross RK, Jambaulikar G, et al
    Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  192. HRADSKY O, Copova I, Zarubova K, Durilova M, et al
    Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  193. O'TOOLE A, Nwanne O, Tomlinson T
    Inflammatory Bowel Disease Increases Risk of Adverse Pregnancy Outcomes: A Meta-Analysis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  194. TAXONERA C, Barreiro-de Acosta M, Calvo M, Saro C, et al
    Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  195. WU XW, Wu L, Ji HZ, Wang FY, et al
    Relationship Between Cytomegalovirus Infection and Steroid Resistance in Inflammatory Bowel Disease: A Meta-Analysis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  196. SAJJADI M, Gholamrezaei A, Daryani NE
    No association between serum adenosine deaminase activity and disease activity in Crohn's disease.
    Dig Dis Sci. 2015;60:1755-60.
    PubMed     Text format     Abstract available


  197. BAIRD AC, Lloyd F, Lawrance IC
    Prostaglandin E(2) and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function.
    Dig Dis Sci. 2015;60:1603-16.
    PubMed     Text format     Abstract available


    May 2015
  198. DEFILIPPIS EM, Kumar S
    Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  199. THAPA SD, Hadid H, Imam W, Hassan A, et al
    Persistent Reactive Thrombocytosis May Increase the Risk of Coronary Artery Disease Among Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  200. TOLSTANOVA G, Deng X, Ahluwalia A, Paunovic B, et al
    Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  201. BRUNO ME, Rogier EW, Arsenescu RI, Flomenhoft DR, et al
    Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  202. CARBONNEL F, Hugot JP
    Which Environmental Factors Cause IBD Relapses?
    Dig Dis Sci. 2015;60:1129-31.
    PubMed     Text format    


  203. KAMATA N, Oshitani N, Watanabe K, Watanabe K, et al
    Efficacy of concomitant elemental diet therapy in scheduled infliximab therapy in patients with Crohn's disease to prevent loss of response.
    Dig Dis Sci. 2015;60:1382-8.
    PubMed     Text format     Abstract available


  204. TURSI A, Elisei W, Picchio M, Giorgetti G, et al
    Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFalpha Antagonists.
    Dig Dis Sci. 2015;60:1406-13.
    PubMed     Text format     Abstract available


  205. MALGRAS B, Pautrat K, Dray X, Pasquier P, et al
    Multidisciplinary management of gastrointestinal fibrotic stenosis in Crohn's disease.
    Dig Dis Sci. 2015;60:1152-68.
    PubMed     Text format     Abstract available


  206. WENZL HH, Primas C, Novacek G, Teml A, et al
    Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease.
    Dig Dis Sci. 2015;60:1414-23.
    PubMed     Text format     Abstract available


    April 2015
  207. BURRI E, Beglinger C, Lehmann FS
    Reply: To PMID 25344905.
    Dig Dis Sci. 2015;60:1109-10.
    PubMed     Text format    


  208. SHAH SA
    Predicting the Need for Imaging in IBD: Radiating Only Badness?
    Dig Dis Sci. 2015;60:813-5.
    PubMed     Text format    


  209. TAO Q, Wang B, Zheng Y, Jiang X, et al
    Vitamin D prevents the intestinal fibrosis via induction of vitamin D receptor and inhibition of transforming growth factor-beta1/Smad3 pathway.
    Dig Dis Sci. 2015;60:868-75.
    PubMed     Text format     Abstract available


  210. JUNG YS, Park DI, Hong SN, Kim ER, et al
    Predictors of Urgent Findings on Abdominopelvic CT in Patients with Crohn's Disease Presenting to the Emergency Department.
    Dig Dis Sci. 2015;60:929-35.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: